MELD ESAS Evolution: Assessment of the Symptomatic Burden of Patients With Advanced Chronic Liver Disease
Conditions: Palliative Care; End Stage Liver DIsease Interventions: Other: ESAS Sponsors: Unidade Local de Sa úde de Matosinhos, EPE Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
Short Term Outcome of Metabolic Associated Fatty Liver Disease (MAFLD) in Patients Undergoing Bariatric Surgery
Conditions: Metabolic Associated Fatty Liver Disease; Bariatric Surgery Candidate Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
Diagnosing and Monitoring Portal Hypertension Non-invasively Using Spleen Stiffness Measurement in Patients With Advanced Chronic Liver Disease: a Prospective Cohort Study
Conditions: Advanced Chronic Liver Disease Sponsors: McGill University Health Centre/Research Institute of the McGill University Health Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
Real-World Validation of a Prognostic Prediction Model for Patients With Acute Exacerbations of Chronic Liver Disease
Conditions: Chronic Liver Disease and Cirrhosis Sponsors: Shanghai Jiao Tong University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease; Non Alcoholic Fatty Liver; Non Alcoholic Steatohepatitis; NAFLD; NASH Interventions: Drug: Hyperpolarized (HP) 13C; Drug: Hyperpolarized 13C-Urea; Procedure: Magnetic Resonance Imaging; Procedure: Saline Flush Sponsors: Michael Ohliger, MD PhD; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
Efficacy of Baclofen Vs Naltrexon in Achieving & Maintaining Abstinence in Alcohol Dependence.
Conditions: Alcohol Liver Disease Interventions: Drug: Naltrexon; Drug: Baclofen Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury
Conditions: End Stage Liver Disease; Jaundice; Liver Dysfunction; Portal Hypertension Interventions: Device: FibroScan ® Expert 630 Sponsors: Nanfang Hospital, Southern Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind Trial
Conditions: Non-alcoholic Fatty Liver Disease Interventions: Other: Ginseng oligopeptide (Ginseng extract ）; Other: Maltodextrin Sponsors: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver Disease
Conditions: Nonalcoholic Fatty Liver Disease Sponsors: Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
Effect of Different Dosage of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD
Conditions: End-stage Liver Diseases Interventions: Biological: umbilical cord-mesenchymal stem cells Sponsors: General Hospital of Shenyang Military Region Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
Conditions: Alpha1-Antitrypsin Deficiency Interventions: Drug: Fazirsiran Injection; Drug: Placebo Sponsors: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Conditions: NASH/MASH; NAFLD/MASLD Interventions: Drug: Efruxifermin; Drug: Placebo Sponsors: Akero Therapeutics, Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
Role of Exercise in Chronic Liver Disease Patients Undergoing Liver Transplantation
Conditions: Chronic Liver Disease and Cirrhosis; Frailty Interventions: Behavioral: Supervised aerobic and resistance exercises; Dietary Supplement: Dietary supplementation Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
D-SOLVE Cohorts (Cohort A and B)
Conditions: HDV; HDV Infection; Chronic Liver Disease Sponsors: Hannover Medical School; Karolinska University Hospital; Karolinska Institutet; Helmholtz Centre for Infection Research; Fondazione IRCCS Ca ' Granda, Ospedale Maggiore Policlinico; National Institute of Infectious Diseases Matei Bals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Outcome of Laparoscopic Appendicectomy Versus Open Appendicectomy in Sudanese Patients
Conditions: General Surgery Interventions: Procedure: Laproscopic Appendicectomy; Procedure: Open Appendicectomy Sponsors: National Center for Gastroentestinal and Liver Disease Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
